WBMD WebMD Health Corp featured news, full reports, and detailed charts
WebMD Health Corp (WBMD) Wrap Up:
WebMD Health Corp. is a Delaware corporation that was incorporated on May 3, 2005 under the name WebMD Health Holdings, Inc. Our principal executive offices are located at 111 Eighth Avenue, New York, New York 10011 and our telephone number is (212) 624-3700. Our Class A Common Stock, which has one vote per share, began trading on the Nasdaq National Market under the symbol “WBMD” on September 29, 2005 and now trades on a successor market, the Nasdaq Global Select Market. For additional information regarding our initial public offering, see Notes 1 and 4 to the Consolidated Financial Statements included in this Annual Report. As of the date of this Annual Report, HLTH Corporation owns all 48,100,000 shares of our Class B Common Stock, which has five votes per share. As of the date of this Annual Report, the Class B Common Stock owned by HLTH represents approximately 84. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f02%2f29%2f0000950144-08-001542.html#FIS_BUSINESS"WebMD Health Corp. (WBMD:NASDAQ)
Snapshot of WebMD Health Corp. (WBMD)
|
OPEN
$36.14
|
PREVIOUS CLOSE
$36.14
|
|
|
DAY HIGH
$36.35
|
DAY LOW
$36.12
|
|
|
52 WEEK HIGH
11/12/09 - $36.75
|
52 WEEK LOW
11/21/08 - $13.63
|
|
|
MARKET CAP
2.1B
|
AVERAGE VOLUME 3 mo
306.6K
|
|
|
DILUTED EPS TTM
$0.95
|
SHARES OUTSTANDING
57.7M
|
|
|
WBMD Does Not Pay Dividends
|
P/E TTM
38.0x
|
|
| K = Thousands M = Millions B = Billions | ||
related news
WBMD Top Compensated Officers
Executives, Board Directors
Key developments for WebMD Health Corp. (WBMD)
WebMD Health Corp. announced that Anthony Vuolo, its Chief Operating Officer, has been appointed to the additional position of Chief Financial Officer. Mr. Vuolo previously served as WebMD's Chief Financial Officer from its initial public offering in 2005 until becoming Chief Operating Officer in 2007. He has served in senior financial, operational and business development positions with WebMD and predecessor companies for more than 15 years. Mr. Vuolo is replacing Mark D. Funston, who is leaving the Company to pursue other opportunities.
WebMD Health Corp. reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009. Revenue for the third quarter was $111.6 million compared to $96.8 million in the prior year period, an increase of 15%. Earnings before interest, taxes, non-cash and other items for the third quarter was $33.1 million or $0.56 per share compared to $25.5 million or $0.43 per share in the prior year period, an increase of 30%. Income from continuing operations for the third quarter was $12.6 million or $0.21 per share compared to $10.0 million or $0.17 per share in the prior year period. Net income for the third quarter was $12.8 million or $0.21 per share, compared to $10.8 million or $0.18 per share in the prior year period. Income from continuing operations before income tax provision for the period was $21.22 million compared to $17.33 million for the same period previous year. For the period, the company reported revenue of $300.46 million compared to $263.45 million for the same period previous year. Income from continuing operations for the period was $22.79 million or $0.39 per diluted share compared to loss from continuing operations was $7.31 million or $0.13 per diluted share in the prior year period. Net income for the third quarter was $17.69 million or $0.30 per share compared to net loss of $6.21 million or $0.11 per share in the prior year period. Income from continuing operations before income tax provision for the period was $38.25 million compared to $8.0 million for the same period previous year. Earnings before interest, taxes, non-cash and other items for the period was $75 million or $1.28 per diluted share compared to $60.19 million or $1.04 per diluted share in the prior year period. Net cash provided by operating activities for the period was $88.20 million compared to $80.75 million for the same period previous year. Expenditure on purchases of property and equipment for the period was $14.13 million compared to $15.01 million for the same period previous year. The company reaffirmed its financial guidance for the fourth quarter and full year 2009 and narrowed the ranges for its anticipated revenue and Adjusted EBITDA by raising the low end of those ranges. This financial guidance reflects the prior financial guidance for the Company's former parent, HLTH Corporation, whose historical financial statements are required to be adopted by WebMD as a result of the merger. For 2009, the company expects total revenue to be approximately $430 million to $440 million, an increase of 15% to 18% over 2008. Adjusted EBITDA to be approximately $106 million to $111 million, an increase of 24% to 25% over 2008. Income from continuing operations to be approximately $11 million to $14 million or $0.22 to $0.27 per share. These amounts represent growth of approximately 19% to 23% in public portal advertising and sponsorship revenue and approximately 2% in private portal services revenue.
WebMD Health Corp. announced that Anthony Vuolo, its Chief Operating Officer, has been appointed to the additional position of Chief Financial Officer. Mr. Vuolo previously served as WebMD's Chief Financial Officer from its initial public offering in 2005 until becoming Chief Operating Officer in 2007. He has served in senior financial, operational and business development positions with WebMD and predecessor companies for more than 15 years.
WBMD Competitors
| Company | Last | Change |
| Continucare Corp | $3.08 USD | -0.01 |
| Global Sources Ltd | $6.05 USD | -0.10 |
| Health Grades Inc | $4.57 USD | +0.08 |
| Healthways Inc | $16.78 USD | -0.21 |
| Metropolitan Health Networks Inc | $1.97 USD | +0.01 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | WBMD | Industry Range |
| Price/Earnings | 38.6x |
|
| Price/Sales | 5.1x |
|
| Price/Book | 3.1x |
|
| Price/Cash Flow | 26.7x |
|
| TEV/Sales | 4.4x |
|
|
WBMD |
||
WBMD transactions
| Type Date |
Target |
|
Buyback
November 3, 2009 |
-- |
|
Merger/Acquisition
June 17, 2009 |
HLTH Corporation |
More Recent News About WebMD Health Corp
More news for WBMD
WEBMD HEALTH CORP. Files SEC form 10-Q, Quarterly Report
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations This Item 2 contains forward-looking statements with respect to possible events, outcomes or results that are, and are expected to continue to be, subject to risks, uncertainties and contingencies, including those identified in this Item. See "Forward-Looking Statements" on page 3. Overview Management's discussion and analysis of financial condition and results of operations, or MD&A, is provided as a supplement to the consolidated financial statements and notes thereto included elsewhere in this Quarterly Report and is intended to provide an understanding of our results of operations, financial condition and changes in financial condition. Our MD&A is organized as follows: • Introduction. This section provides a general description of our company, background information on certain trends and developments affecting our company, a description of our merger with HLTH Corporation (which we refer to as the HLTH Merger) and certain effects of the HLTH Merger and a discussion of how seasonal factors may impact the timing of our revenue. • Critical Accounting Policies and Estimates. This section discusses those accounting policies that are considered important to the evaluation and reporting of our financial condition and results of operations, and whose application requires us to exercise subjective and often complex judgments in making estimates and assumptions. In addition, all of our significant accounting policies, including our critical accounting policies, are summarized in Note 2 to the Consolidated Financial Statements contained in Exhibit 99.3 to the Current Report on Form 8-K that we filed on July 2, 2009 with the Securities and Exchange Commission (which we refer to as the SEC). • Transactions with HLTH. This section describes the services that we received from HLTH Corporation (which we refer to as HLTH) and the costs of thes...Click here to read the whole Article (external link)
Bulls Buy Cephalon, WebMD:Options Recap
Stock quotes in this article: CEPH , CVS , AES , ...Click here to read the whole Article (external link)
WebMD Health Corp. Announces Commencement of Tender Offer to Repurchase Up to 5,700,000 Shares of Its Common Stock at Price of $37.00 Per Share
NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD - News) announced today that it has commenced its tender offer to purchase up to 5,700,000 shares of its common stock at a price per share of $37.00. The price per share of $37.00 represents a change from the price per share of $36.00 that WebMD previously announced on November 3, 2009. The number of shares proposed to be purchased in the tender offer represents approximately 10% of WebMD's currently outstanding shares. The last reported sales price per share of WebMD Common Stock on the NASDAQ Global Select Market on November 9, 2009 was $35.75 per share. The tender offer will expire at 5:00 p.m., New York City time, on Thursday, December 10, 2009, unless extended by WebMD. Tenders of shares must be made on or prior to the expiration of the tender offer and may be withdrawn at any time on or prior to the expiration of the tender offer. The tender offer is subject to a number of terms and conditions described in the Offer to Purchase that is being distributed to stockholders.On the terms and subject to the conditions of the tender offer, WebMD's stockholders will have the opportunity to tender some or all of their shares at a price of $37.00 per share. If stockholders properly tender and do not properly withdraw more than 5,700,000 shares, WebMD will purchase shares tendered by those stockholders owning fewer than 100 shares, without pro ration, and all other shares tendered will be purchased on a pro rata basis, subject to the condition...Click here to read the whole Article (external link)
WebMD Announces Drugs.com to Join the WebMD Health Network
NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD - News), the leading source of health information, announced today that it has entered into an alliance with Drugs.com to exclusively integrate Drugs.com's advertising inventory and online traffic into the WebMD Health Network. Drugs.com provides free, accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Effective January 1, 2010, Drugs.com will be integrated into the WebMD Health Network. "Drugs.com is one of very few sites that have developed a loyal base of users that are of high interest and high value to biopharmaceutical and consumer products companies," said Wayne Gattinella, CEO and President of WebMD. "We are very pleased to be partnering with Drugs.com to further establish the WebMD Health Network as the premier source of drug reference information for consumers and health care professionals."About WebMDWebMD Health Corp. (Nasdaq: WBMD - News) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portal...Click here to read the whole Article (external link)
WEBMD HEALTH CORP. Files SEC form 8-K, Change in Directors or Principal Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Grant of Restricted Stock to Martin J. Wygod. On November 3, 2009, Mr. Wygod was granted 110,000 shares of restricted WebMD Common Stock, 25% of which is scheduled to vest on each of the first four anniversaries of the date of grant. The amount of shares granted, and the terms of the grant, were determined by the Compensation Committee of the Board of Directors of WebMD (the "Compensation Committee"), in its discretion. In making such grant, the Compensation Committee took into consideration that, under the terms of Mr. Wygod's existing employment agreement, Mr. Wygod's salary was reduced from $975,000 per year to $120,000 per year upon the completion of the merger of HLTH Corporation ("HLTH") and WebMD (the "HLTH Merger"). Pursuant to the terms of WebMD's Amended and Restated 2005 Long-Term Incentive Plan, the vesting of the restricted stock will be accelerated, in the event of termination of Mr. Wygod's employment as a result of death or permanent disability, to the date of such termination. In addition, vesting would be accelerated, under the provisions of Mr. Wygod's existing employment agreement, upon a termination without cause by the Registrant or by Mr. Wygod for good reason or upon a change in control. Pursuant to General Instruction B.3 of Form 8-K, the following is incorporated by reference in this Item 5.02 from the Joint Proxy Statement/Prospectus (the "Merger Proxy Statement/Prospectus") filed by WebMD with the Commission pursuant to Rule 424(b)(3) on September 15, 2009 (Registration No. 333-160530): • the description of the employment agreement between HLTH and Mr. Wygod contained under the caption "WebMD Executive Compensation - Employment Agreements with the WebMD Named Executive Officers - Martin J. Wygod"; and • the information contained under t...Click here to read the whole Article (external link)
[$$] Drug Makers to Press for Guidance on Web Marketing
Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question. Q: How are tools like Twitter [micro bloging, Twitter.com] shaping consumers and human networks? Please fill out the answer field. The language you used does not comply with community standards. Please re-enter. ...Click here to read the whole Article (external link)
WebMD Health commences tender offer of 5.7M shares
Copyright © 2009 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Report Problems Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quote data delayed 15 minutes for Nasdaq, NYSE and Amex. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Yahoo! is not an investment adviser and does not provide, endorse or review any information or data contained herein....Click here to read the whole Article (external link)
WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference
Copyright © 2009 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Report Problems Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quote data delayed 15 minutes for Nasdaq, NYSE and Amex. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Yahoo! is not an investment adviser and does not provide, endorse or review any information or data contained herein....Click here to read the whole Article (external link)
WEBMD HEALTH CORP. Financials
PERIOD ENDING30-Sep-0930-Jun-0931-Mar-0931-Dec-08Total Revenue111,568 98,631 90,264 111,532 Cost of Revenue41,965 39,229 36,565 38,708 Gross Profit69,603 59,402 53,699 72,824 Operating ExpensesResearch Development - - - - Selling General and Administrative42,226 41,936 42,287 45,072 Non Recurring - - - 2,910 Others6,988 6,804 6,937 7,185 Total Operating Expenses - - - - Operating Income or Loss20,389 10,662 4,475 17,657 Income from Continuing OperationsTotal Other Income/Expenses Net834 924 975 2,033 Earnings Before Interest And Taxes21,223 11,586 5,450 19,690 Interest Expense - - - - Income Before Tax21,223 11,586 5,450 19,690 Income Tax Expense8,622 4,636 2,211 (13,364)Minority Interest - - - - Net Income From Continuing Ops12,601 6,950 3,239 33,054 Non-recurring EventsDiscontinued Operations190 (4,867)(423)(135)Extraordinary Items - - - - Effect Of Accounting Changes...Click here to read the whole Article (external link)